(Q51799265)

12 April 2018

title

Identification of small-molecule inhibitors of the JIP-JNK interaction. (English)

1 reference

12 April 2018

author name string

Tracy Chen

1

1 reference

12 April 2018

Natasha Kablaoui

2

1 reference

12 April 2018

Jeremy Little

3

1 reference

12 April 2018

Sergei Timofeevski

4

1 reference

12 April 2018

William R Tschantz

5

1 reference

12 April 2018

Ping Chen

6

1 reference

12 April 2018

Junli Feng

7

1 reference

12 April 2018

Maura Charlton

8

1 reference

12 April 2018

Robert Stanton

9

1 reference

12 April 2018

Paul Bauer

10

1 reference

12 April 2018

language of work or name

English

0 references

publication date

13 May 2009

1 reference

12 April 2018

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Biochemical Journal

1 reference

12 April 2018

volume

420

1 reference

12 April 2018

issue

2

1 reference

12 April 2018

page(s)

283-294

1 reference

12 April 2018

Mammalian MAP kinase signalling cascades

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Phosphorylation of c-jun mediated by MAP kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

From receptors to stress-activated MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Signal transduction by the JNK group of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Targeting JNK for therapeutic benefit: from junk to gold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

JNK: a new therapeutic target for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

A central role for JNK in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

A cytoplasmic inhibitor of the JNK signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

The JIP family of MAPK scaffold proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

A mammalian scaffold complex that selectively mediates MAP kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Requirement of the JIP1 scaffold protein for stress-induced JNK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Identification of the critical features of a small peptide inhibitor of JNK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Small-molecule inhibitors of protein-protein interactions: progressing towards the dream

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Structure-based maximal affinity model predicts small-molecule druggability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Identification of a new JNK inhibitor targeting the JNK-JIP interaction site

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Homogeneous and nonradioactive high-throughput screening platform for the characterization of kinase inhibitors in cell lysates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Specificity and mechanism of action of some commonly used protein kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Mechanistic characterization for c-jun-N-Terminal Kinase 1alpha1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Discovery of novel isothiazole inhibitors of the TrkA kinase: structure-activity relationship, computer modeling, optimization, and identification of highly potent antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Molecular basis of MAPK-activated protein kinase 2:p38 assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

Kinetic mechanism and inhibitor characterization for c-jun-N-terminal kinase 3alpha1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20081899

21 January 2018

Identifiers

DOI

10.1042/BJ20081899

1 reference

12 April 2018

PubMed ID

19243309

1 reference

12 April 2018